Search - Prime Therapeutics
Navigate to
-
Drug pricing information All drugs listed on the National Average Drug Acquisition Cost (NADAC) list that are reimbursed at rates either 10% below or 10% above the national average drug...
-
publications Quarterly Drug Approvals: January 2025 This report provides an overview of new drugs and indications approved in 2024 January 31, 2025 Specialty drug approvals Specialty drug...
-
publications Quarterly Drug Approvals: April 2025 This report provides an overview of new drugs and indications approved in 2025 April 24, 2025 Specialty drug approvals Specialty drug approvals -...
-
publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 October 31, 2024 Specialty drug approvals Specialty drug...
-
Connect care for your members with cancer IntegratedRx® – Oncology puts everyone on the same team and gives members a central location for their cancer medicines. Breadcrumb Home Our solutions...
-
Connect care for your members with cystic fibrosis IntegratedRx – Cystic Fibrosis helps deliver an integrated care experience for members and their providers. Breadcrumb Home Our solutions...
-
Provide a uniquely integrated experience More connected care helps curb costs and improve the experience for your members with cancer and cystic fibrosis. Breadcrumb Home Our solutions Specialty...
-
See the latest FDA drug recalls We monitor Food and Drug Administration (FDA) recall notices to keep you in the know. 2025 Jul. 15 | Sulfamethoxazole / Trimethoprim, 400 mg/80 mg | Amneal Jan. 31 |...